In summary, these studies suggest that persistent phosphorylated tau may underlie neurodegeneration, and the different forms of tau protein may contribute to the molecular basis of distinct tau protein “strains, “leading to the wide clinical and neuropathological heterogeneity observed in tauopathies (Sanders et al., 2014). This evidence concerns the gene MAPT and tauopathy.